Sector Update: Healthcare Shares Flat; Allergan Upgraded to Outperform at Wells Fargo

By
A A A

Healthcare stocks:

JNJ: +0.20%

PFE: flat

ABT: flat

MRK: flat

AMGN: flat

Healthcare shares are flat in pre-market trade.

Pharmaceutical company Allergan, Inc. ( AGN ) has been upgraded by analysts at Wells Fargo to Outperform from Market Perform. The firm raised its price target range to $121-$122 from $99-$100.

In the pre-market session, shares of AGN were level at $107.39, within a 52-week spread of $81.33 - $116.45.

And, Genetic Technologies ( GENE ) said today in an SEC filing that it has now granted a license to Bio-Reference Laboratories ( BRLI ). Terms of the deal were not disclosed.

The company says it is now actively pursuing its patent Assertion Programme in USA, and says several "significant cases" are now pending in the District of Delaware - including cases against Bristol Myers Squibb ( BMY ) and Pfizer ( PFE ).



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: AGN , BMY , BRLI , GENE , PFE

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

36,586,989
  • $41.35 ▼ 2.29%
33,435,019
  • $42.20 ▼ 10.86%
31,919,424
  • $9.72 ▼ 8.30%
30,045,396
  • $26.49 ▼ 1.41%
29,014,873
  • $8.05 ▼ 8%
27,308,018
  • $14.66 ▼ 8.32%
23,704,242
  • $118.93 ▼ 0.06%
23,514,654
  • $17.04 ▼ 0.41%
As of 11/28/2014, 01:06 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com